ArticleBMC veterinary research2026
First report of Atriotaenia tapeworms and Sarcocystis protists in invasive raccoons (Procyon lotor) from Lithuania.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identification and characterization ofInternational journal for parasitology. Parasites and wildlife · 2026Article
- Microscopic and Molecular Identification ofBiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe raccoon (Procyon lotor), an introduced species in Europe, has exhibited significant population growth and successful adaptation to synanthropic environments over recent decades. In newly colonised areas, knowledge gaps remain regarding various aspects of raccoon ecology, including its behaviour, as well as associated parasites. The majority of pathogens identified in European raccoon populations to date possess documented epizootic and zoonotic potential. The objective of this study was to detect muscle parasites (Alaria spp., Sarcocystis spp., and Trichinella spp.) and to characterize Sarcocystis protists in intestinal scrapings of raccoons, as well as to visually inspect helminth species in six fecal samples.
methodsDuring the 2018–2022 period, muscle, fecal and intestinal samples of 13 animals were examined. Sarcocysts of Sarcocystis protists and Cyclophyllidea tapeworms were morphologically characterized using light microscope (LM). Sarcocystis species were identified by means of 28 S rRNA, ITS1, and cox1 sequence analysis. Cyclophyllidea tapeworms were confirmed by 12 S rRNA sequence analysis.
resultsMicroscopic analysis revealed the presence of Sarcocystis parasites and Cyclophyllidea tapeworms in seven (53.8%) of the raccoons examined. No Trichinella nematodes or Alaria trematodes were detected in the muscle samples by using an active artificial digestion method. In the small intestine, oocysts and/or sporocysts of Sarcocystis spp. were observed by LM in five of the samples. One species of Atriotaenia cestode was detected in fecal samples of two raccoons. Based on DNA sequence results, Sarcocystis lutrae was identified in the muscles of a single raccoon from Lithuania. The present study provides the first report of seven distinct Sarcocystis taxa identified in raccoon intestines by molecular analyses, including Sarcocystis rileyi, which forms macroscopic sarcocysts in ducks, and Sarcocystis bovifelis, which infects cattle muscles. Based on 12 S rRNA sequencing, Atriotaenia incisa was identified in two of the examined animals.
conclusionsOur findings expand current knowledge on the Sarcocystis species richness in carnivores. This study also reports the first identification of A. incisa in the feces of raccoons from Lithuania. This study demonstrates that broader sampling and detailed parasitological investigations are essential for a more complete characterization of raccoon parasite diversity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.